Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

Shares of Apple and Dell Technologies rise after the Trump administration exempts smartphones, computers, memory chips, and ...

SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals based on ...

Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like ...

Pfizer has ended development of danuglipron, an oral GLP-1 drug for weight management, citing clinical data and regulatory input.